REQUEST A DEMO
Total
USD $0.00
Search more companies

Daebong LS Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Daebong LS Co.,Ltd. Profile Updated: August 20, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Daebong LS Co.,Ltd. is engaged in manufacturing and distribution of various raw materials for the cold permanent wave, cosmetics, food additives and pharmaceuticals. The company's products includes Ammonium thioglycolate, Monoethanolamine thioglycolate, Ticlopidine hydrochloride, Acepifylline, Cystine, S-Carboxymethylcysteine, L-Cysteine, L-Cysteine·HCl·H2O, N-Acetyl-L-Cysteine, DL-Cysteine·HCl·H2O, DL-Cysteine, Erdosteine, Acebrophylline, Piroxicam β-Cyclodextrin, Terbinafine hydrochloride, L-Tyrosine, DL-Carnitine hydrochloride, among others. Daebong LS Co.,Ltd. is based in Incheon, South Korea. The company was incorporated in 1986 formerly known as Daebong Co., Ltd.

Headquarters
692-8 Kojan-Dong, Namdong-Gu
Incheon; Incheon; Postal Code: 405-820

Contact Details: Purchase the Daebong LS Co.,Ltd. report to view the information.

Website: http://www.daebongls.co.kr

Basic Information
Total Employees:
Purchase the Daebong LS Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Daebong LS Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Daebong LS Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Daebong LS Co.,Ltd. report to view the information.
Incorporation Date:
July 08, 1986
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
24.76%
Purchase this report to view the information.
18.09%
Purchase this report to view the information.
2.72%
Purchase this report to view the information.
2.62%
Purchase this report to view the information.
1.98%
Subsidiaries
코셀러코리아㈜
75.25%
대봉엘에프영어조합법인
35.73%
바름메디
25%
Company Performance
Financial values in the chart are available after Daebong LS Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
12.82%
Total operating revenue
13.55%
Operating profit (EBIT)
86.59%
EBITDA
59.04%
Net Profit (Loss) for the Period
143.11%
Total assets
21.89%
Total equity
9.61%
Operating Profit Margin (ROS)
5.69%
Net Profit Margin
7.64%
Return on Equity (ROE)
1.22%
Debt to Equity Ratio
11.72%
Quick Ratio
1.19%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?